Basal cell carcinoma
MONDO:0020804A carcinoma involving the basal cells.
Also known as: basal cell cancer, epithelioma, basal cell, malignant basal cell neoplasm
2863 clinical trials for this condition and its sub-types, 112 tagged with Basal cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Basal cell carcinoma
-
Skin basal cell carcinoma 52 trials · 60 incl. sub-types
25 sub-types
- Nodular basal cell carcinoma 8 trials
- Superficial multifocal basal cell carcinoma 7 trials
- Basosquamous carcinoma 1 trial
- Morpheaform basal cell carcinoma 1 trial
- Skin infiltrative basal cell carcinoma 1 trial
- Adamantinoid basal cell epithelioma 0 trials
- Anal margin basal cell carcinoma 0 trials
- External ear basal cell carcinoma 0 trials
- Follicular atrophoderma-basal cell carcinoma 0 trials
- Follicular basal cell carcinoma 0 trials
- Infundibulocystic basal cell carcinoma 0 trials
- Metatypical basal cell carcinoma 0 trials
- Micronodular basal cell carcinoma 0 trials
- Penis basal cell carcinoma 0 trials
- Salivary gland basal cell adenocarcinoma 0 trials
- Sarcomatoid basal cell carcinoma 0 trials
- Scrotum basal cell carcinoma 0 trials
- Sebaceous basal cell carcinoma 0 trials
- Signet ring basal cell carcinoma 0 trials
- Skin adenoid basal cell carcinoma 0 trials Sub-types →
- Skin clear cell basal cell carcinoma 0 trials
- Skin cystic basal cell carcinoma 0 trials
- Skin fibroepithelial basal cell carcinoma 0 trials
- Skin pigmented basal cell carcinoma 0 trials
- Vulva basal cell carcinoma 0 trials
Most studied deeper sub-types
-
Could a gel cut down on skin cancer surgeries? new trial investigates
Disease control Stopped earlyThis trial tests a gel called patidegib applied to the face twice daily for 9 months in people who develop many basal cell carcinomas (a common skin cancer) but do not have Gorlin syndrome. The goal is to see if the gel reduces the number of new skin cancers that would normally r…
Phase 2 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Experimental combo therapy shows promise in advanced cancers, but trial halted early
Disease control Stopped earlyThis study tested whether injecting vidutolimod directly into tumors plus giving cemiplimab through a vein could shrink cancers that have spread. The trial included 77 people with several types of advanced cancer. Unfortunately, the study was stopped early, so we have less inform…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Chemo patch for skin cancer shows promise in early trial
Disease control Stopped earlyThis early-stage study tested a new way to deliver the chemotherapy drug doxorubicin directly into basal cell skin cancer using tiny dissolving needles on a patch. The goal was to find a safe dose and see if it could completely remove the cancer. The study included 13 adults with…
Phase 1 • Sponsor: SkinJect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Radioactive seeds zapped tumors from the inside — but trial stopped early
Disease control Stopped earlyThis early study tested a device that places radioactive seeds directly into skin, mouth, or soft tissue tumors. The seeds release alpha radiation to kill cancer cells from within. Only 2 people took part before the trial was stopped, so we don't have enough information to know i…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Experimental cancer drug trial ends early
Disease control Stopped earlyThis early-stage study tested an experimental drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
AI mole checker tested at home – but trial stops early
Diagnosis Stopped earlyThis study tested whether a device called the Sklip System, which uses artificial intelligence, could help people at home decide if a mole might be skin cancer. Only one person took part before the study was stopped early. The goal was to see if the AI could match or beat standar…
Sponsor: OHSU Knight Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC